Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Affordable Care Act
    • Consumer-Driven Health Care
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Drug Prices & Regulations
    • Health Economics & Costs
    • Health Insurance
    • Health Reform
    • Medical Tourism
    • Medicare
    • Single-Payer/Medicare-for-All
    • Telemedicine
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Category: Cost of Healthcare

Thursday Links

Posted on September 28, 2023September 27, 2023 by John C. Goodman
  • Cosco is offering virtual checkups for $29. Third party insurance not accepted.
  • Headline: Pharma would lose loyal ally if Menendez leaves Senate. If he is so loyal, why didn’t he stop the IRA bill?
  • Frequently wrong, New York Times covid reporter Apoorva Mandavilli will lecture at Harvard (alongside former Chicago Mayor Lori Lightfoot).
  • The more governments intervene to protect workers, the more unemployment there is.
  • Why hospital consolidation is hurting patients and what can be done about it.
+

House W & M to Mark up Two HSA Bills

Posted on September 27, 2023 by John C. Goodman

Here is a quick summary, courtesy of Dan Perrin, of how the House Ways & Means Committee will mark up two HSA Bills.

+

The New York Times (and the FDA) Does a Hatchet Job on Regenerative Medicine

Posted on September 26, 2023 by Devon Herrick

The New York Times did a hatchet job on regenerative medicine. A visiting researcher at New York-Presbyterian/Weill Cornell Medical Center and other surgeons had performed numerous surgeries using BioBurst, a processed umbilical cord fluid, to help fuse together bones in minimally invasive surgeries. The fluid was administered to reduce healing time and reduce the need for more invasive back surgery.

+

Monday Links

Posted on September 25, 2023September 25, 2023 by John C. Goodman
  • Health gains from key prescription drugs.
  • Steve Henke, et. al., skewer a new Royal Society report on Covid-19.
  • Health Affairs study:  employers lack leverage to negotiate lower prices. Have they never heard of reference pricing?
  • CDC: we are losing the battle against obesity. I thought we lost it a long time ago.
  • Inequities at the doctors office: is it because the patients don’t speak up for themselves?
+
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 134
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 15 other subscribers

Popular Topics

©2023 The Goodman Institute Health Blog | Website by Lexicom